Related Experiment Videos
[New central analgesic-acting triaminopyridines]
P Emig1, B Nickel, C H Weischer
1Forschung der Asta Medica AG, Frankfurt/Main.
Arzneimittel-Forschung
|June 1, 1993
Summary
Researchers developed a novel compound, D-19050, demonstrating potent central and peripheral analgesic effects. This new triaminopyridine derivative offers rapid onset, prolonged action, and a favorable safety profile for pain management.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Context:
- Development of novel analgesic compounds is crucial for effective pain management.
- Existing analgesics often have limitations including side effects and limited efficacy.
Purpose:
- To synthesize and characterize a new triaminopyridine derivative, D-19050.
- To evaluate the analgesic activity and pharmacokinetic properties of D-19050.
Summary:
- 2-Amino-3-((prop-1-en-3-yl)oxycarbonylamino)-6-(4-fluorobenzylamino) pyridine hydrochloride (D-19050) is a novel centrally and peripherally acting analgesic.
- D-19050 exhibits rapid onset, long duration of action, and a good therapeutic range.
- The compound can be synthesized in a 5-step process starting from 2,6-dichloropyridine.
Impact:
- D-19050 represents a promising candidate for a new class of analgesics.
- The findings may lead to improved pain management strategies with enhanced efficacy and safety.
- The synthetic route provides a basis for further optimization and scale-up.